International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.13756300
Original Research Article
Visual Outcome and Complications after Nd:YAG Laser Capsulotomy in Patients with Posterior Capsular Opacification - An Observational Study
Published
Sept. 13, 2024
Abstract

Purpose:To compare the visual outcome and different complications after Nd:YAG Laser Capsulotomy in patients with Posterior Capsular Opacity and analyse the changes in intraocular pressure following Nd:YAG laser capsulotomy.Patients and methods:All the patients reporting at the OPD were evaluated clinically and by proper history which included type of cataract surgery performed along with the date of surgery, and its functional impairment and symptoms of patients. A complete pre laser and post laser work up was done. Posterior Capsulotomy was performed with Nd:YAG Laser starting from a minimum pulse energy and then gradually increasing the energy.Results:To Significant visual improvement was seen 1 hr after laser capsulotomy. 12.7% of patients had improved visual acuity of 3/60-6/60 and 55.9% patients had VA of 6/60- 6/18 and 27.9% had improved visual acuity of 6/12-6/6; 4 patients showed no visual improvement in VA. The percentage of patients with better visual acuity had increased gradually during follow up period – at 24 Hours, 1 week, 1 month and 3 months. At the end of 3 months, 3.3% of patients had VA of less than 3/60. 0.84%% of patients had VA of 3/60- 6/60, 26.27% of patients had VA of 6/36- 6/18, and 69.49% of patients had VA of 6/12-6/6.Conclusion:The Nd:YAG laser is a noninvasive surgical tool that provides excellent posterior capsulotomies. It safe, least time consuming and readily acceptable to patients can be done as a day care procedure, thus preferred over surgical intervention that is, manual surgicalcapsulotomy.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1563 Views
279 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved